{
    "title": "GSK lifts profit margin forecast on healthy demand for drugs giant's Shingles vaccine and HIV medicines",
    "url": "https://www.dailymail.co.uk/money/markets/article-11380697/GSK-lifts-forecast-amid-high-demand-Shingles-vaccine-new-HIV-medicines.html",
    "date": "2022-11-02",
    "keywords": [
        "cent",
        "share",
        "turnover",
        "business",
        "risk",
        "investment",
        "fund",
        "gsk",
        "demand",
        "hiv",
        "giant",
        "currency",
        "year",
        "treatment",
        "quarter",
        "covid19",
        "boost",
        "glaxosmithkline",
        "medicine",
        "performance",
        "heartburn",
        "drug",
        "zantac",
        "platform",
        "issue",
        "account",
        "fee",
        "outlook",
        "vaccine",
        "julyit",
        "record",
        "shingrix",
        "jump",
        "half",
        "growth",
        "yeardemand",
        "specialty",
        "guidance",
        "input",
        "coronavirus",
        "dovato",
        "juluca",
        "glaxo",
        "pharma",
        "drugmaker",
        "meritless",
        "article",
        "companys",
        "category",
        "expansion",
        "medication",
        "trelegy",
        "rebound",
        "marketthis",
        "increase",
        "walmsley",
        "executive",
        "momentum",
        "confidence",
        "wednesday",
        "value",
        "august",
        "stomach",
        "antihistamine",
        "acid",
        "impurity",
        "ndma",
        "factor",
        "israel",
        "cancersgsk",
        "cancer",
        "ranitidine",
        "evidence",
        "drugmark",
        "analyst",
        "etoro",
        "controversy",
        "drag",
        "pricehe",
        "liability",
        "something",
        "eye",
        "capital",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}